Good news for 200,000 uninsured individuals all over the country. Thanks to a partnership with the Centers for Disease Control and Prevention, pharmaceutical company Gilead will donate 2.4 million bottles of Truvada to them over the next 11 years.
Both the United States government and Gilead were forthcoming about how the partnership came about, with Health and Human Services Secretary Alex Azar talking about it in a Twitter thread and Gilead releasing a press release after.
According to Azar, the agreement “will provide pre-exposure prophylaxis (PrEP) to treat individuals who are at risk for HIV and who are uninsured, including in the states and counties identified as priority areas in @POTUS’s plan to #EndHIVEpidemic in America.”
In another tweet in the thread, Azar trumpeted Trump’s leadership, saying it allowed the government “to secure preventative medication for uninsured individuals at risk for #HIV who might otherwise not be able to access or afford this important treatment.”
Gilead, meanwhile, believes the donation will help end the HIV epidemic in the United States. In the statement, Gilead’s chief patient officer, Gregg Alton, said: “We believe today’s donation, combined with efforts to address the root causes of the epidemic, such as racism, violence against women, stigma, homophobia and transphobia, can play an important role in ending the HIV epidemic in the United States, particularly in parts of the country with the highest burden of disease.”
That said, there are no details as to when the program will start or the application process uninsured people have to go through to acquire the medicine.
This news comes on the heels of the recent announcement that a generic version of Truvada will be out in the market in 2020.
How do you guys feel about this new program? To our Adam4Adam blog readers who unfortunately have no insurance, how big of a help will this be to you? Share your thought with us in the comments section below.